Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
12.58
+0.15 (1.21%)
At close: Dec 5, 2025, 4:00 PM EST
14.00
+1.42 (11.29%)
After-hours: Dec 5, 2025, 7:59 PM EST
Ocular Therapeutix Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 2,680 | 1,343 | 492 | 216 | 534 | 1,559 | |
| Market Cap Growth | 91.11% | 173.13% | 127.16% | -59.47% | -65.74% | 720.77% | |
| Enterprise Value | 2,412 | 991 | 464 | 155 | 413 | 1,546 | |
| Last Close Price | 12.58 | 8.54 | 4.46 | 2.81 | 6.97 | 20.70 | |
| PS Ratio | 39.14 | 21.07 | 8.41 | 4.20 | 12.27 | 89.57 | |
| PB Ratio | 8.52 | 4.26 | 5.39 | 6.12 | 6.07 | 20.48 | |
| P/TBV Ratio | 10.38 | 4.26 | 5.39 | 6.12 | 6.07 | 20.48 | |
| EV/Sales Ratio | 43.25 | 15.54 | 7.94 | 3.01 | 9.50 | 88.85 | |
| Debt / Equity Ratio | 0.30 | 0.24 | 0.92 | 1.82 | 0.67 | 0.77 | |
| Asset Turnover | 0.12 | 0.18 | 0.29 | 0.29 | 0.19 | 0.10 | |
| Inventory Turnover | 65.67 | 49.86 | 31.01 | 35.98 | 44.46 | 28.56 | |
| Quick Ratio | 7.62 | 10.27 | 6.36 | 3.94 | 7.04 | 9.01 | |
| Current Ratio | 7.85 | 10.66 | 6.66 | 4.13 | 7.26 | 9.23 | |
| Return on Equity (ROE) | -81.83% | -95.21% | -127.64% | -115.16% | -7.99% | -429.55% | |
| Return on Assets (ROA) | -36.61% | -30.53% | -25.66% | -27.76% | -20.90% | -23.06% | |
| Return on Capital (ROIC) | -43.27% | -38.31% | -37.56% | -39.86% | -34.65% | -41.29% | |
| Return on Capital Employed (ROCE) | -73.00% | -41.60% | -37.90% | -66.70% | -43.70% | -26.70% | |
| Earnings Yield | -9.32% | -14.41% | -16.42% | -32.83% | -1.23% | -9.98% | |
| FCF Yield | -7.44% | -10.13% | -15.53% | -29.26% | -12.50% | -3.49% | |
| Buyback Yield / Dilution | -26.34% | -84.90% | -3.57% | -0.59% | -35.24% | -34.19% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.